This startup offers health and wellness supplements formulated to mitigate the negative side effects of cannabis use. Their flagship product, Janey, is designed to reduce cardiovascular inflammation associated with D9-THC consumption.
Funding
Funding not disclosed
Founders
Product
Problem
Cannabis use, particularly D9-THC, has been shown to cause cardiovascular inflammation and oxidative stress, potentially leading to long-term heart issues. Many cannabis users are unaware of these risks or lack convenient methods to mitigate them.
Solution
Janey offers a gummy supplement formulated with Genistein and other heart-healthy ingredients designed to counteract the negative cardiovascular effects of THC. The supplement aims to balance the cannabis experience by addressing inflammation and oxidative stress induced by THC consumption. By incorporating Janey into their routine, cannabis users can proactively support their heart health while still enjoying the benefits of cannabis. The gummies provide a convenient and palatable way to deliver a precise dose of Genistein, which preclinical trials suggest can block the damaging effects of D9-THC.
Target Audience
The primary target audience includes adults who consume cannabis and are looking for a proactive way to support their cardiovascular health and mitigate potential negative side effects.
Features
- Contains 500mg of non-soy, naturally derived Genistein per serving, dosed based on Stanford University School of Medicine studies.
- Includes Vitamin B12 for healthy nerve and blood cell function.
- Contains Chlorella, rich in omega-3 fatty acids, for detoxification and immune support.
- Includes Vitamin D3 for supporting healthy bones, nerves, and brain health.
- Includes Potassium for maintaining healthy blood pressure and muscle function.
- Vegan, gluten-free, soy-free, and dairy-free formulation.
- Made with natural flavors and colors.